Search research articles
Contact Us
Filters
Showing results (111-120 of 129) with videos related to
Page
of 13
Sort By:
Leukemia
|
September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
Laetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
American Journal of Hematology
|
November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
Alicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Blood
|
May 13, 2026
Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study
Nicolas Boissel, Françoise Huguet, Thibaut Tl Leguay, et al.
Blood
|
August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
Rathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood Cancer Journal
|
May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Jerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Blood
|
April 29, 2016
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL
Philippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, et al.
Haematologica
|
April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
Sophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Blood
|
November 18, 2017
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
Olivier Bluteau, Marie Sebert, Thierry Leblanc, et al.
Science Translational Medicine
|
July 12, 2019
A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i>-mutated myelodysplastic syndrome
Sabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, et al.
Blood
|
October 24, 2025
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
Nicolas Boissel, Sylvie Chevret, Françoise Rigal-Huguet, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 129) with videos related to
Sort By:
Page
of 13
Leukemia
|
September 18, 2020
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
Laetitia Largeaud, Pascale Cornillet-Lefebvre, Jean-François Hamel, et al.
American Journal of Hematology
|
November 27, 2023
Outcomes of CMML patients undergoing allo-HCT are significantly worse compared to MDS-a study of the CMWP of the EBMT
Alicia Rovó, Luuk Gras, Brian Piepenbroek, et al.
Blood
|
May 13, 2026
Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study
Nicolas Boissel, Françoise Huguet, Thibaut Tl Leguay, et al.
Blood
|
August 18, 2023
Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
Rathana Kim, Hugo Bergugnat, Cédric Pastoret, et al.
Blood Cancer Journal
|
May 29, 2020
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Jerome Paillassa, Edouard Cornet, Stephanie Noel, et al.
Blood
|
April 29, 2016
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL
Philippe Rousselot, Marie Magdelaine Coudé, Nicola Gokbuget, et al.
Haematologica
|
April 4, 2020
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study
Sophie Vantyghem, Pierre Peterlin, Sylvain Thépot, et al.
Blood
|
November 18, 2017
A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
Olivier Bluteau, Marie Sebert, Thierry Leblanc, et al.
Science Translational Medicine
|
July 12, 2019
A variant erythroferrone disrupts iron homeostasis in <i>SF3B1</i>-mutated myelodysplastic syndrome
Sabrina Bondu, Anne-Sophie Alary, Carine Lefèvre, et al.
Blood
|
October 24, 2025
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial
Nicolas Boissel, Sylvie Chevret, Françoise Rigal-Huguet, et al.
Page
of 13